Understanding how leucine affects energy generation could lead to therapies for metabolic disorders, fatigue syndromes, and age-related diseases involving reduced mitochondrial efficiency
IGF-1 activates the PI3K/Akt/mTOR pathway in muscle cells, stimulating protein synthesis, nitrogen retention, and hypertrophy
That's medicine, and we treat it that way
can be custom requirements, depending on the agency that you are applying for For a more detailed breakdown of these requirements refer to: The Phases Depending on the stage or need of your startup, the SBIR program offers multiple grant application pathways: Phase 1/I: All startups irrespective of the stage of your company are eligible only for Phase 1
P450 2A6 (CYP2A6) metabolizes nicotine, leading to oxidative stress and the generation of harmful metabolites, which can cause liver damage and lung cancer